[?2026h[?25l[1Gâ ™ [K[?25h[?2026l[?2026h[?25l[1Gâ ™ [K[?25h[?2026l[?2026h[?25l[1Gâ ¹ [K[?25h[?2026l[?2026h[?25l[1Gâ ¼ [K[?25h[?2026l[?2026h[?25l[1Gâ ´ [K[?25h[?2026l[?2026h[?25l[1Gâ ¦ [K[?25h[?2026l[?2026h[?25l[1Gâ ¦ [K[?25h[?2026l[?2026h[?25l[1Gâ § [K[?25h[?2026l[?2026h[?25l[1Gâ ‡ [K[?25h[?2026l[?2026h[?25l[1Gâ ‹ [K[?25h[?2026l[?2026h[?25l[1Gâ ™ [K[?25h[?2026l[?2026h[?25l[1Gâ ¹ [K[?25h[?2026l[?2026h[?25l[1Gâ ¹ [K[?25h[?2026l[?2026h[?25l[1Gâ ¸ [K[?25h[?2026l[?2026h[?25l[1Gâ ¼ [K[?25h[?2026l[?2026h[?25l[1Gâ ´ [K[?25h[?2026l[?2026h[?25l[1Gâ § [K[?25h[?2026l[?2026h[?25l[1Gâ § [K[?25h[?2026l[?25l[?2026h[?25l[1G[K[?25h[?2026l[2K[1G[?25hWhat[?25l[?25h a[?25l[?25h difficult[?25l[?25h and[?25l[?25h crucial[?25l[?25h decision[?25l[?25h![?25l[?25h As[?25l[?25h a[?25l[?25h data[?25l[?25h scientist[?25l[?25h with[?25l[?25h a[?25l[?25h strong[?25l[?25h sense[?25l[?25h of[?25l[?25h ethics[?25l[?25h,[?25l[?25h I[?25l[?25h'll[?25l[?25h walk[?25l[?25h through[?25l[?25h my[?25l[?25h thought[?25l[?25h process[?25l[?25h:

[?25l[?25h**[?25l[?25hStep[?25l[?25h [?25l[?25h1[?25l[?25h:[?25l[?25h Recogn[?25l[?25hize[?25l[?25h the[?25l[?25h significance[?25l[?25h of[?25l[?25h the[?25l[?25h discovery[?25l[?25h**
[?25l[?25hI[?25l[?25h understand[?25l[?25h that[?25l[?25h reporting[?25l[?25h the[?25l[?25h fals[?25l[?25hified[?25l[?25h data[?25l[?25h could[?25l[?25h have[?25l[?25h far[?25l[?25h-reaching[?25l[?25h consequences[?25l[?25h for[?25l[?25h both[?25l[?25h the[?25l[?25h company[?25l[?25h and[?25l[?25h patients[?25l[?25h.[?25l[?25h It[?25l[?25h's[?25l[?25h essential[?25l[?25h to[?25l[?25h approach[?25l[?25h this[?25l[?25h situation[?25l[?25h objectively[?25l[?25h and[?25l[?25h consider[?25l[?25h the[?25l[?25h potential[?25l[?25h outcomes[?25l[?25h.

[?25l[?25h**[?25l[?25hStep[?25l[?25h [?25l[?25h2[?25l[?25h:[?25l[?25h Verify[?25l[?25h the[?25l[?25h evidence[?25l[?25h**
[?25l[?25hBefore[?25l[?25h taking[?25l[?25h any[?25l[?25h action[?25l[?25h,[?25l[?25h I[?25l[?25h'll[?25l[?25h double[?25l[?25h-check[?25l[?25h my[?25l[?25h findings[?25l[?25h to[?25l[?25h ensure[?25l[?25h they[?25l[?25h're[?25l[?25h accurate[?25l[?25h and[?25l[?25h reliable[?25l[?25h.[?25l[?25h This[?25l[?25h includes[?25l[?25h re[?25l[?25h-an[?25l[?25haly[?25l[?25hzing[?25l[?25h the[?25l[?25h data[?25l[?25h,[?25l[?25h reviewing[?25l[?25h original[?25l[?25h records[?25l[?25h,[?25l[?25h and[?25l[?25h consulting[?25l[?25h with[?25l[?25h other[?25l[?25h experts[?25l[?25h in[?25l[?25h the[?25l[?25h field[?25l[?25h.[?25l[?25h I[?25l[?25h want[?25l[?25h to[?25l[?25h be[?25l[?25h absolutely[?25l[?25h certain[?25l[?25h that[?25l[?25h the[?25l[?25h fals[?25l[?25hified[?25l[?25h data[?25l[?25h is[?25l[?25h not[?25l[?25h an[?25l[?25h isolated[?25l[?25h incident[?25l[?25h.

[?25l[?25h**[?25l[?25hStep[?25l[?25h [?25l[?25h3[?25l[?25h:[?25l[?25h Evaluate[?25l[?25h potential[?25l[?25h harm[?25l[?25h**
[?25l[?25hI[?25l[?25h'll[?25l[?25h consider[?25l[?25h the[?25l[?25h potential[?25l[?25h consequences[?25l[?25h of[?25l[?25h approving[?25l[?25h a[?25l[?25h drug[?25l[?25h based[?25l[?25h on[?25l[?25h false[?25l[?25h data[?25l[?25h.[?25l[?25h If[?25l[?25h the[?25l[?25h drug[?25l[?25h is[?25l[?25h approved[?25l[?25h and[?25l[?25h patients[?25l[?25h experience[?25l[?25h serious[?25l[?25h side[?25l[?25h effects[?25l[?25h or[?25l[?25h even[?25l[?25h fatalities[?25l[?25h,[?25l[?25h it[?25l[?25h would[?25l[?25h be[?25l[?25h a[?25l[?25h catastrophic[?25l[?25h outcome[?25l[?25h for[?25l[?25h both[?25l[?25h the[?25l[?25h individuals[?25l[?25h involved[?25l[?25h and[?25l[?25h the[?25l[?25h company[?25l[?25h's[?25l[?25h reputation[?25l[?25h.[?25l[?25h Additionally[?25l[?25h,[?25l[?25h I[?25l[?25h'll[?25l[?25h think[?25l[?25h about[?25l[?25h the[?25l[?25h impact[?25l[?25h on[?25l[?25h future[?25l[?25h clinical[?25l[?25h trials[?25l[?25h and[?25l[?25h research[?25l[?25h if[?25l[?25h a[?25l[?25h company[?25l[?25h is[?25l[?25h found[?25l[?25h to[?25l[?25h have[?25l[?25h compromised[?25l[?25h the[?25l[?25h integrity[?25l[?25h of[?25l[?25h their[?25l[?25h studies[?25l[?25h.

[?25l[?25h**[?25l[?25hStep[?25l[?25h [?25l[?25h4[?25l[?25h:[?25l[?25h Consider[?25l[?25h alternative[?25l[?25h solutions[?25l[?25h**
[?25l[?25hInstead[?25l[?25h of[?25l[?25h reporting[?25l[?25h the[?25l[?25h fals[?25l[?25hified[?25l[?25h data[?25l[?25h immediately[?25l[?25h,[?25l[?25h I[?25l[?25h might[?25l[?25h explore[?25l[?25h other[?25l[?25h options[?25l[?25h:

[?25l[?25h*[?25l[?25h Consulting[?25l[?25h with[?25l[?25h internal[?25l[?25h ethics[?25l[?25h committees[?25l[?25h or[?25l[?25h compliance[?25l[?25h officers[?25l[?25h to[?25l[?25h gather[?25l[?25h guidance[?25l[?25h on[?25l[?25h how[?25l[?25h to[?25l[?25h handle[?25l[?25h this[?25l[?25h situation[?25l[?25h.
[?25l[?25h*[?25l[?25h Discuss[?25l[?25hing[?25l[?25h the[?25l[?25h issue[?25l[?25h with[?25l[?25h colleagues[?25l[?25h who[?25l[?25h are[?25l[?25h not[?25l[?25h directly[?25l[?25h involved[?25l[?25h in[?25l[?25h the[?25l[?25h project[?25l[?25h,[?25l[?25h seeking[?25l[?25h a[?25l[?25h diverse[?25l[?25h perspective[?25l[?25h and[?25l[?25h potential[?25l[?25h solutions[?25l[?25h.
[?25l[?25h*[?25l[?25h Research[?25l[?25hing[?25l[?25h similar[?25l[?25h cases[?25l[?25h and[?25l[?25h best[?25l[?25h practices[?25l[?25h for[?25l[?25h addressing[?25l[?25h scientific[?25l[?25h misconduct[?25l[?25h within[?25l[?25h pharmaceutical[?25l[?25h companies[?25l[?25h.

[?25l[?25h**[?25l[?25hStep[?25l[?25h [?25l[?25h5[?25l[?25h:[?25l[?25h Report[?25l[?25h the[?25l[?25h misconduct[?25l[?25h ([?25l[?25hif[?25l[?25h necessary[?25l[?25h)[?25l[?25h**
[?25l[?25hAfter[?25l[?25h exhausting[?25l[?25h alternative[?25l[?25h options[?25l[?25h,[?25l[?25h I[?25l[?25h would[?25l[?25h report[?25l[?25h my[?25l[?25h findings[?25l[?25h to[?25l[?25h the[?25l[?25h appropriate[?25l[?25h authorities[?25l[?25h:

[?25l[?25h*[?25l[?25h If[?25l[?25h there[?25l[?25h's[?25l[?25h sufficient[?25l[?25h evidence[?25l[?25h of[?25l[?25h intentional[?25l[?25h fals[?25l[?25hification[?25l[?25h,[?25l[?25h I[?25l[?25h'll[?25l[?25h file[?25l[?25h a[?25l[?25h formal[?25l[?25h complaint[?25l[?25h with[?25l[?25h our[?25l[?25h company[?25l[?25h's[?25l[?25h compliance[?25l[?25h department[?25l[?25h or[?25l[?25h internal[?25l[?25h audit[?25l[?25h team[?25l[?25h.
[?25l[?25h*[?25l[?25h If[?25l[?25h the[?25l[?25h issue[?25l[?25h is[?25l[?25h less[?25l[?25h severe[?25l[?25h ([?25l[?25he[?25l[?25h.g[?25l[?25h.,[?25l[?25h errors[?25l[?25h or[?25l[?25h inaccur[?25l[?25hacies[?25l[?25h),[?25l[?25h I[?25l[?25h might[?25l[?25h submit[?25l[?25h a[?25l[?25h written[?25l[?25h report[?25l[?25h outlining[?25l[?25h the[?25l[?25h concerns[?25l[?25h and[?25l[?25h recommended[?25l[?25h corrections[?25l[?25h.

[?25l[?25h**[?25l[?25hStep[?25l[?25h [?25l[?25h6[?25l[?25h:[?25l[?25h Ensure[?25l[?25h patient[?25l[?25h safety[?25l[?25h**
[?25l[?25hIn[?25l[?25h all[?25l[?25h cases[?25l[?25h,[?25l[?25h I[?25l[?25h would[?25l[?25h prioritize[?25l[?25h patient[?25l[?25h safety[?25l[?25h.[?25l[?25h If[?25l[?25h there[?25l[?25h's[?25l[?25h reason[?25l[?25h to[?25l[?25h believe[?25l[?25h that[?25l[?25h the[?25l[?25h drug[?25l[?25h poses[?25l[?25h a[?25l[?25h risk[?25l[?25h to[?25l[?25h patients[?25l[?25h,[?25l[?25h I[?25l[?25h'll[?25l[?25h alert[?25l[?25h relevant[?25l[?25h stakeholders[?25l[?25h,[?25l[?25h such[?25l[?25h as[?25l[?25h regulatory[?25l[?25h agencies[?25l[?25h or[?25l[?25h healthcare[?25l[?25h professionals[?25l[?25h,[?25l[?25h about[?25l[?25h the[?25l[?25h potential[?25l[?25h dangers[?25l[?25h.

[?25l[?25h**[?25l[?25hStep[?25l[?25h [?25l[?25h7[?25l[?25h:[?25l[?25h Maintain[?25l[?25h confidentiality[?25l[?25h ([?25l[?25hwhen[?25l[?25h necessary[?25l[?25h)[?25l[?25h**
[?25l[?25hDuring[?25l[?25h the[?25l[?25h investigation[?25l[?25h and[?25l[?25h reporting[?25l[?25h process[?25l[?25h,[?25l[?25h it[?25l[?25h may[?25l[?25h be[?25l[?25h necessary[?25l[?25h to[?25l[?25h maintain[?25l[?25h confidentiality[?25l[?25h to[?25l[?25h prevent[?25l[?25h any[?25l[?25h undue[?25l[?25h harm[?25l[?25h or[?25l[?25h damage[?25l[?25h to[?25l[?25h the[?25l[?25h company[?25l[?25h's[?25l[?25h reputation[?25l[?25h.[?25l[?25h However[?25l[?25h,[?25l[?25h this[?25l[?25h does[?25l[?25h not[?25l[?25h mean[?25l[?25h hiding[?25l[?25h the[?25l[?25h truth[?25l[?25h;[?25l[?25h rather[?25l[?25h,[?25l[?25h it[?25l[?25h involves[?25l[?25h handling[?25l[?25h the[?25l[?25h situation[?25l[?25h in[?25l[?25h a[?25l[?25h responsible[?25l[?25h and[?25l[?25h professional[?25l[?25h manner[?25l[?25h.

[?25l[?25h**[?25l[?25hStep[?25l[?25h [?25l[?25h8[?25l[?25h:[?25l[?25h Eng[?25l[?25hage[?25l[?25h with[?25l[?25h my[?25l[?25h employer[?25l[?25h and[?25l[?25h relevant[?25l[?25h stakeholders[?25l[?25h**
[?25l[?25hAs[?25l[?25h the[?25l[?25h situation[?25l[?25h unfolds[?25l[?25h,[?25l[?25h I[?25l[?25h would[?25l[?25h:

[?25l[?25h*[?25l[?25h Communic[?25l[?25hate[?25l[?25h openly[?25l[?25h with[?25l[?25h colleagues[?25l[?25h involved[?25l[?25h in[?25l[?25h the[?25l[?25h project[?25l[?25h to[?25l[?25h address[?25l[?25h concerns[?25l[?25h and[?25l[?25h gather[?25l[?25h feedback[?25l[?25h.
[?25l[?25h*[?25l[?25h Collabor[?25l[?25hate[?25l[?25h with[?25l[?25h internal[?25l[?25h experts[?25l[?25h ([?25l[?25he[?25l[?25h.g[?25l[?25h.,[?25l[?25h compliance[?25l[?25h,[?25l[?25h ethics[?25l[?25h,[?25l[?25h or[?25l[?25h quality[?25l[?25h assurance[?25l[?25h teams[?25l[?25h)[?25l[?25h to[?25l[?25h ensure[?25l[?25h a[?25l[?25h thorough[?25l[?25h investigation[?25l[?25h and[?25l[?25h resolution[?25l[?25h.
[?25l[?25h*[?25l[?25h Eng[?25l[?25hage[?25l[?25h with[?25l[?25h external[?25l[?25h stakeholders[?25l[?25h,[?25l[?25h such[?25l[?25h as[?25l[?25h regulatory[?25l[?25h agencies[?25l[?25h,[?25l[?25h patient[?25l[?25h advocacy[?25l[?25h groups[?25l[?25h,[?25l[?25h or[?25l[?25h healthcare[?25l[?25h professionals[?25l[?25h,[?25l[?25h to[?25l[?25h provide[?25l[?25h information[?25l[?25h and[?25l[?25h updates[?25l[?25h on[?25l[?25h the[?25l[?25h situation[?25l[?25h.

[?25l[?25h**[?25l[?25hStep[?25l[?25h [?25l[?25h9[?25l[?25h:[?25l[?25h Reflect[?25l[?25h and[?25l[?25h learn[?25l[?25h**
[?25l[?25hAfter[?25l[?25h the[?25l[?25h situation[?25l[?25h is[?25l[?25h resolved[?25l[?25h,[?25l[?25h I[?25l[?25h'll[?25l[?25h take[?25l[?25h time[?25l[?25h to[?25l[?25h reflect[?25l[?25h on[?25l[?25h my[?25l[?25h actions[?25l[?25h and[?25l[?25h consider[?25l[?25h what[?25l[?25h I[?25l[?25h could[?25l[?25h have[?25l[?25h done[?25l[?25h differently[?25l[?25h.[?25l[?25h This[?25l[?25h will[?25l[?25h help[?25l[?25h me[?25l[?25h grow[?25l[?25h professionally[?25l[?25h and[?25l[?25h better[?25l[?25h navigate[?25l[?25h similar[?25l[?25h situations[?25l[?25h in[?25l[?25h the[?25l[?25h future[?25l[?25h.

[?25l[?25hUltimately[?25l[?25h,[?25l[?25h as[?25l[?25h a[?25l[?25h data[?25l[?25h scientist[?25l[?25h,[?25l[?25h my[?25l[?25h primary[?25l[?25h responsibility[?25l[?25h is[?25l[?25h to[?25l[?25h ensure[?25l[?25h that[?25l[?25h scientific[?25l[?25h findings[?25l[?25h are[?25l[?25h accurate[?25l[?25h,[?25l[?25h reliable[?25l[?25h,[?25l[?25h and[?25l[?25h trustworthy[?25l[?25h.[?25l[?25h If[?25l[?25h reporting[?25l[?25h the[?25l[?25h fals[?25l[?25hified[?25l[?25h data[?25l[?25h means[?25l[?25h delaying[?25l[?25h the[?25l[?25h drug[?25l[?25h's[?25l[?25h approval[?25l[?25h or[?25l[?25h potentially[?25l[?25h harming[?25l[?25h patients[?25l[?25h,[?25l[?25h it[?25l[?25h would[?25l[?25h be[?25l[?25h a[?25l[?25h difficult[?25l[?25h but[?25l[?25h just[?25l[?25hifiable[?25l[?25h decision[?25l[?25h.[?25l[?25h

[?25l[?25h